Clinical Trial Update: Neoadjuvant Therapy for the Treatment of Gastroesophageal Junction and Gastric Cancers [Phase 1]

View source ↗

Summary

A Phase 1 neoadjuvant therapy trial for gastroesophageal junction and gastric cancers has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Adenocarcinoma
• Gastric Cancer
• Gastroesophageal Junction Adenocarcinoma

Snippet

Sponsor: Ohio State University Comprehensive Cancer Center | Conditions: Clinical Stage I Gastric Cancer AJCC v8, Clinical Stage II Gastric Cancer AJCC v8 | Phase 1 | Status: WITHDRAWN